Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation
en-GBde-DEes-ESfr-FR

Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation

08/12/2025 Compuscript Ltd
https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0028
Announcing a new article publication for Cardiovascular Innovations and Applications journal. A new real-world analysis using data from the Tianjin Health and Medical Big Data Super Platform provides the first large-scale clinical insights from Asia into anticoagulation practices for patients with acute myocardial infarction (AMI) and preexisting atrial fibrillation (AF), a population known to be at heightened risk for adverse cardiovascular events.
This study addresses a critical evidence gap regarding the contemporary use of direct oral anticoagulants alongside antiplatelet therapy, revealing that rivaroxaban is prescribed in combination therapy in 18.7% of Chinese patients with AMI and AF. The findings show that rivaroxaban use is associated with a reduced risk of stroke without an accompanying increase in bleeding events, offering new evidence to inform clinical decision-making for this high-risk population.
# # # # # #
CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Ying Liu, Yi Zheng and Gregory Y. H. Lip et al. Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2025.0028
Ying Liu, Yi Zheng and Gregory Y. H. Lip et al. Effects of Rivaroxaban on Prognosis in Patients with Acute Myocardial Infarction and Preexisting Atrial Fibrillation. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2025.0028
08/12/2025 Compuscript Ltd
Regions: Europe, Ireland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...

  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement